Heart Cancels 2024 Tour Due to Ann Wilson's Cancer Treatment

Heart Cancels 2024 Tour Due to Ann Wilson's Cancer Treatment

Heart has postponed the remaining dates of its 2024 North American Royal Flush Tour and supporting dates for the Journey/Def Leppard stadium tour due to health concerns for lead singer Ann Wilson. Wilson, who recently underwent a successful operation to remove a cancerous tumor, has been advised by doctors to undergo preventive chemotherapy and take the rest of the year off to recover. The band had also previously canceled their European tour dates earlier this year for a routine medical procedure.

Wilson, who turned 74 this year, expressed her intention to return to the stage in 2025. The postponed dates include numerous shows across the U.S. and Canada, with ticket holders being assured that their tickets will be honored for the rescheduled performances. The band's management is working to confirm new dates, and fans are encouraged to hold onto their tickets. Heart, known for hits like "Magic Man" and "Barracuda," will continue to update fans on Wilson's recovery and future tour plans.

Summary